Evaluation and Management of Rectourethral Fistula Following Radiation Treatment for Prostate Cancer

详细信息    查看全文

• 作者：Ramón Virasoro (1)
  Mary H. James (2)
  Kurt A. McCammon (1) (3)
  
• 关键词：Radiotherapy ; Complications ; Rectal fistula ; Urethral fistula ; Prostate cancer
• 刊名：Current Bladder Dysfunction Reports
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：7
• 期：4
• 页码：275-280
• 全文大小：121KB
• 参考文献：1. Bukowski TP, Chakrabarty A, Powell J, et al. Acquired rectourethral fistula: methods of repair. J Urol. 1995;153:730-. CrossRef
  2. -Buckley JC. Complications after radical prostatectomy: anastomotic stricture and rectourethral fistula. Curr Opin Urol. 2011;21:461-. / This is a detailed recent review on the management of complications after radical prostatectomy, including RUF. CrossRef
  3. Lane BR, Stein DE, Remzi FH, et al. Management of radiotherapy induced rectourethral fistula. J Urol. 2006;175:1382-. CrossRef
  4. Zinman L. The management of the complex rectourethral fistula. BJU Int 2004; 94:1212.
  5. Stack RS, Swierzewski M, Schellhammer PF, et al. Radiation injuries of the urinary tract: Etiology, incidence and management. AUA Update XIX. 2000;7:50-.
  6. Chrouser KL, Leibovich BC, Sweat SD, et al. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol. 2005;173:1953-. CrossRef
  7. Hu K, Wallner K. Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;41:263. CrossRef
  8. Cherr GS, Hall C, Pineau BC, et al. Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report. Am Surg. 2001;67(2):131-.
  9. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol. 2002;41:427. CrossRef
  10. Moreira SG, Seigne JD, Ordorica RC, et al. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int. 2004;93:31-. CrossRef
  11. ?-Mundy AR, Andrich DE. Urorectal fistulae following the treatment of prostate cancer. BJU Int. 2010;107:1298-03. / This article proposes a stratification of patients in an attempt to define further management. They challenge the traditional management in selected patients, in whom they did not performed protective colostomy or interposition flap. CrossRef
  12. ?-Vanni AJ, Buckley JC, Zinman LN. Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft. J Urol. 2010;184:2400-. / This article presents the largest series of radiation induced RUF, all managed very successfully with a single approach. CrossRef
  13. Nyam DC, Pemberton JH. Management of iatrogenic RUF. Dis Colon Rectum. 1999;42:994-. CrossRef
  14. Thomas C, Jones J, Jager W, et al. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol. 2010;183:608-2. CrossRef
  15. -Hadley DA, Sothwick A and Middleton RG. York-Mason procedure for repair of rectourinary fistulae: a 40-year experience. BJU Int 2011; 109(7):1095-. Epub 2011 Oct 28. / Though the radiation induced RUF are in small numbers, they present the longest follow up with the York-Mason technique.
  16. -Samplaski MK, Wood HM, Lane BR, et al. Functional and quality-of-life outcomes in patients undergoing transperineal repair with gracilis muscle interposition for complex rectourethral fistula. Urology. 2011;77(3):736-1. / This is the first publication assessing the quality of life of patients undergoing repair of RUF through the perineal approach with muscle interposition. CrossRef
  17. Zinman L. Muscular, myocutaneous, and fasciocutaneous flaps in complex urethral reconstruction. Urol Clin North Am. 2002;29(2):443-6. CrossRef
  18. Ryan JA, Beebe HJ, Gibbons RP. Gracilis muscle flap for closure of rectourethral fistula. J Urol. 1979;122:124.
  19. Gupta G, Kumar S, Kekre NS, et al. Surgical management of rectourethral fistula. Urology. 2008;71:267. CrossRef
  20. Ulrich D, Roos J, Jaske G, et al. Gracilis muscle interposition for the treatment of recto-urethral and rectovaginal fistulas: a retrospective analysis of 35 cases. J Plast Reconstr Aesthet Surg. 2009;62:352. CrossRef
  21. Baker SS, McCammon KA, Schlossberg SM, et al. Repair of prostate-urethral-rectal fistulas. J Urol. 1999;161(4):103. abstract 285. CrossRef
  22. Arcangeli S, Pinzi V, Arcangeli G. Epidemiology of prostate cancer and treatment remarks. World J Radiol. 2012;4(6):241-. CrossRef
  23. Cooperberg MR, Grossfeld GD, Lubeck DP, et al. National Practice Patterns and time trends in androgen ablation for localized prostate cancer. J Nat Cancer Inst. 2003;95:981. CrossRef
  24. Uchida T, Shoji S, Nakano M, et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int. 2010;107:378-2. CrossRef
  25. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 1996;14:449-3.
  26. Goffinet D, Martinez A, Freiha F, et al. 125-Iodine prostate implants for recurrent carcinomas after external beam irradiation: preliminary results. Cancer. 1980;45:2717-4. CrossRef
  27. Abadir R, Ross GJ, Weinstein S. Carcinoma of the prostate treated by pelvic node dissection, iodine-125 seed implant and external radiation: a study of rectal complications. Clin Radiol. 1984;35:359-1. CrossRef
  28. Jordan GH, Lynch DW, Warden SS, McGraw JD, Hoffmann GC, Schellhammer PF. Major rectal complications following interstitial implantation of 125-Iodine for carcinoma of the prostate. J Urol. 1985;134:1212-.
  29. Kleinberg L, Wallner K, Roy J, et al. Treatment-related symptoms during the first year following transperineal 125-I prostate implantation. Int J Radiat Oncol Biol Phys. 1994;28:985-0. CrossRef
  30. Merrick GS, Butler WM, Dorsey AT, Lief JH, Walbert HL, Blatt HJ. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43:1021-. CrossRef
  31. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32:465-1. CrossRef
  32. Zelefsky MJ, Yamada Y, Cohen GN, et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67:65-0. CrossRef
  33. Zelefsky MJ, Yamada Y, Cohen GA, et al. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Radiother Oncol. 2007;84:185-. CrossRef
  34. Martin A-G, Roy J, Beaulieu L, Pouliot J, Harel F, Vigneault E. Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: a 12-year Canadian experience. Int J Radiat Oncol Biol Phys. 2007;67:334-1. CrossRef
  
• 作者单位：Ramón Virasoro (1)
  Mary H. James (2)
  Kurt A. McCammon (1) (3)
  
  1. Devine- Jordan Center for Reconstructive Surgery and Pelvic Health at Urology of Virginia PLLC, Eastern Virginia Medical School, 225 Clearfield Avenue, Virginia Beach, VA, 23462, USA
  2. Adult and Pediatric Reconstructive Surgery, Eastern Virginia Medical School, 225 Clearfield Avenue, Virginia Beach, VA, 23462, USA
  3. Department of Urology, Eastern Virginia Medical School, Norfolk, VA, USA
  

文摘

Rectourethral Fistula (RUF) is an unusual entity with severe consequences to patients. Radiation induced RUF is an infrequent complication following prostate cancer treatment. Evaluation and management of radiation induced RUF is not uniform. A variety of alternatives are offered to manage RUF, including but not limited to the transanal, transrectal approach (York-Mason), pure perineal and combined abdomino-perineal approaches. It is of utmost importance that the genitourinary reconstructive surgeon be familiar with the etiology, anatomy and options to treat RUF. Treatment strategies must be tailored with consideration toward the etiology of the fistula and to the patient status.